Skip to main content

Policy and Legislation

By Susan Morse | 11:06 am | January 03, 2023
The drug was estimated to cost Medicare $12B in one year, representing 36% of the 2018 Part B budget.
By Susan Morse | 11:14 am | December 30, 2022
The proposed rule would restore the longstanding process for the handling of conscience complaints, HHS says.
By HIMSS TV | 06:00 am | December 30, 2022
<p>The chief innovation officer for the Translational Research Institute for Space Health, James Hury, discusses the programs of greatest interest to the HIMSS audience, including collaboration opportunities.</p>
By Susan Morse | 10:53 am | December 29, 2022
The XBB variant, which is resistant to immunity, now makes up over half of cases in New England.
By Susan Morse | 11:08 am | December 28, 2022
The legislation extends waivers for both programs that were put in place under the public health emergency.
By Susan Morse | 11:23 am | December 27, 2022
States may begin processing Medicaid redeterminations on April 1, 2023, and have one year to complete them.
By Jeff Lagasse | 10:37 am | December 22, 2022
Transparent ownership data, the agency says, benefits the public by assisting patients in making better informed decisions about care.
By HIMSS TV | 06:00 am | December 22, 2022
<p>Abigail Katz and Leslie Iburg with United Language Group talk about the challenges that come with eventual expiration of the federal public health emergency and what is needed to reach beneficiaries.</p>
By Jeff Lagasse | 03:20 pm | December 21, 2022
Last week ASPR extended flexibility to states to use Tamiflu in state stockpiles that were previously reserved for a pandemic flu.
By Jeff Lagasse | 04:33 pm | December 20, 2022
When the next phase of the final rule's rollout occurs in January, payers will need to be ready for a new world of price transparency.